Hexafluronium Bromide (BioDeep_00000794477)

   


代谢物信息卡片


Hexafluorenium bromide

化学式: C36H42Br2N2 (660.1714532000001)
中文名称: 己芴溴铵
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.[Br-].[Br-]
InChI: /p-2

描述信息

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D006584 - Hexamethonium Compounds
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

同义名列表

2 个代谢物同义名

Hexafluorenium bromide; Hexafluronium Bromide



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • M E Koller, H Breivik, P Greider, D J Jones, R B Smith. Synergistic effect of acidosis and succinylcholine-induced hyperkalemia in spinal cord transected rats. Acta anaesthesiologica Scandinavica. 1984 Feb; 28(1):87-90. doi: 10.1111/j.1399-6576.1984.tb02017.x. [PMID: 6711267]
  • C P Siegers, C D Klaassen. [The importance of the biliary excretion of drugs in the human]. Deutsche medizinische Wochenschrift (1946). 1983 Oct; 108(41):1564-70. doi: 10.1055/s-2008-1069787. [PMID: 6352227]
  • P A Radnay, E S El-Gaweet, M Novakovic, R Badola, S Cizmar, D Duncalf. Prevention of succinylcholine induced hyperkalemia by neurolept anesthesia and hexafluorenium in anephric patients. Der Anaesthesist. 1981 Jul; 30(7):334-7. doi: NULL. [PMID: 6455928]
  • P Westra, M C Houwertjes, H Wesseling, D K Meijer. Bile salts and neuromuscular blocking agents. British journal of anaesthesia. 1981 Apr; 53(4):407-15. doi: 10.1093/bja/53.4.407. [PMID: 6112011]
  • J W Kleine, A Moesker. Hexafluorenium in renal failure. Anaesthesia. 1978 Jul; 33(7):649-50. doi: 10.1111/j.1365-2044.1978.tb08449.x. [PMID: 686343]
  • F R Schuh. Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium. Naunyn-Schmiedeberg's archives of pharmacology. 1976; 293(1):11-3. doi: 10.1007/bf00498865. [PMID: 948350]
  • A Baraka. Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase. British journal of anaesthesia. 1975 Aug; 47(8):885-8. doi: 10.1093/bja/47.8.885. [PMID: 1201167]